Prostate-Specific Antigen (PSA) Testing Market Drivers, Trends, and Forecast by 2031

MARKET INTRODUCTION

Prostate-specific antigen (PSA) is a type of glycoprotein secreted by prostatic epithelial cells. The higher levels of the PSA indicate a higher chance of being affected by prostate cancer. Though not a prostate-specific molecule, its elevated presence in blood serum is used to detect prostate cancer among men. Increased levels of PSA are associated with prostatitis, an inflammation of the prostate gland, or is indicative of a benign form of prostatic hyperplasia.

MARKET DYNAMICS

The prostate-specific antigen (PSA) testing market is anticipated to grow owing to the rise in awareness levels regarding the availability of advanced cancer diagnostics technologies, especially in the emerging regions. However, increasing the prevalence of the disease will have a significant impact on market development. Moreover, supportive initiatives by various governments across the globe drive market growth.

MARKET SCOPE

The "Prostate-Specific Antigen (PSA) Testing Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in prostate-specific antigen (PSA) testing market with detailed market segmentation by test type, assays type and geography. The prostate-specific antigen (PSA) testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in prostate-specific antigen (PSA) testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The prostate-specific antigen (PSA) testing market is segmented on the basis of test type and assays type. Based on test type the market is segmented as total prostate specific antigen test (tPSA), complex prostate specific antigen test (cPSA), free prostate specific antigen test (fPSA), prostate specific antigen reverse transcription polymerase chain reaction test (PSA RT-PCR), PCA3test, trans-rectal ultrasound and Biopsy. On the basis of assays type the market is categorized as radioimmunoassay (RIA) and enzyme immunoassay (EIA).

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in prostate-specific antigen (PSA) testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prostate-specific antigen (PSA) testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting prostate-specific antigen (PSA) testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the prostate-specific antigen (PSA) testing market in these regions.

MARKET PLAYERS

The report covers key developments in the in prostate-specific antigen (PSA) testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in prostate-specific antigen (PSA) testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for in prostate-specific antigen (PSA) testing market in the global market. Below mentioned is the list of few companies engaged in the prostate-specific antigen (PSA) testing market.

The report also includes the profiles of key in prostate-specific antigen (PSA) testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Abbott Laboratories, Inc.
- AstraZeneca plc.
- Bayer AG
- Beckman Coulter, Inc.
- Bristol - Myers Squibb Company
- GE Healthcare
- GlaxoSmithKline, plc
- Merck & Co., Inc.
- Novartis Pharma AG
- UroLogix, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Prostate-Specific Antigen (PSA) Testing Report Scope